ExactAntigen

PPARG antibody - immunohistochemistry | antibody review based on formal publications
PPARG antibodies
This is a review about PPARG antibodies, based on 6 published articles using PPARG antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited PPARG antibody.
  all  ChIP assay  EMSA  immunocytochemistry  immunohistochemistry  immunoprecipitation  western blot   
Cell Signaling Technology    search Cell Signaling Technology PPARG products
ih, wbCell Signaling Technology anti-PPAR gamma antibody was used in western blot and immunohistochemistry to study the interaction of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas. to the paper
ih, wbCell Signaling anti-PPAR gamma antibody was used in western blot and immunohistochemistry to detect PPAR gamma expression in intestinal epithelium of B. vulgatus-monoassociated germ-free Fisher rats. to the paper
Santa Cruz Biotechnology    search Santa Cruz Biotechnology PPARG products
ihSanta Cruz Biotech PPARG antibody was tested in immunohistochemistry by HPA (CAB004282) . to the paper
ihSanta Cruz Biotechnology PPARgamma antibody was used in immunohistochemistry to study the biological function of peroxisome proliferator-activated receptor gamma and ligands. to the paper
ihSanta Cruz Biotechnology monoclonal anti-PPARgamma antibody E8 was used in immunohistochemistry to detect PPARgamma in human follicular thyroid tissue. to the paper
ihSanta Cruz Biotechnology anti-PPAR antibody was used in immunohistochemistry to study the expression of PAX8-PPARgamma1 rearrangements in both follicular thyroid carcinomas and adenomas. to the paper
Articles Reviewed
1:Anja Persson et al. A human protein atlas based on antibody proteomics. 2006
2:Gita Ohlsson et al. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. 2005
3:Pedro A Ruiz et al. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. 2004
4:Li Yang et al. Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung. 2003
5:Linda Cheung et al. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. 2003
6:Ana Rita Marques et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. 2002


2008©ExactAntigen home | browse | about